Objective: We are very pleased to introduce a special issue of the International Journal of Eating Disorders on child and adolescent feeding and eating disorders and avoidant/ restrictive food intake disorder (ARFID). Results: These papers highlight the importance of clear operationalization and measurement of the ARFID diagnostic criteria. ARFID phenotypes bear both similarities and important differences in clinical profile, course, and outcome from AN. Findings suggest the utility of adapting existing treatments for restrictive eating disorders to apply to ARFID and engender clinical creativity to move beyond existing treatments and develop novel interventions that address the heterogeneity of ARFID. Furthermore, burgeoning understanding of ARFID offers the potential that novel treatments for ARFID may also be applied to improve outcomes for AN.
| INTRODUCTION
We are delighted to introduce a special issue of the International Journal of Eating Disorders on child and adolescent feeding and eating disorders, with a focus on ARFID. Although in most cases feeding and eating disorders onset during childhood and adolescence, much of our existing knowledge base draws on data from adults. With the advent of DSM-5, many young people whose symptoms may have previously been overlooked now meet criteria for understudied diagnoses included in the combined feeding and eating disorders category, including ARFID.
However, little is known about the etiology, assessment, and treatment of ARFID. Given that we study what we define, having names and definitions for these disorders has fostered an explosion of research on these topics over the past 6 years. In the original call for papers for this special issue, we welcomed papers that might advance the field of child and adolescent eating disorders, with particular focus on newly recognized disorders that have been understudied to date. Ultimately the vast majority of submissions focused on restrictive eating disorders-ARFID and anorexia nervosa (AN)-which makes good sense given their earlier age of onset in comparison to binge-eating/purging type disorders. Notable contributions focused on five main themes: (1) the definition and assessment of ARFID; (2) the clinical phenomenology of ARFID; (3) similarities and differences between ARFID and AN; (4) novel treatments for ARFID; and (5) new ideas for improving treatment outcomes in AN.
| DEFINITION AND ASSESSMENT OF ARFID
In a comprehensive and thoughtful review of the nearly 100 papers published on ARFID since its introduction to the diagnostic nomenclature in 2013, Strand, von Hausswolff-Juhlin, and Welch (2019) remind us that the diagnostic boundaries and definition of ARFID remain unclear. Not only is ARFID a heterogeneous diagnosis by design, but clinicians and researchers are defining it somewhat differently across studies. Rising to this challenge, Eddy et al. (2019) describe how researchers might specifically operationalize diagnostic criteria for ARFID to ensure that the disorder is characterized similarly across studies and that findings can be appropriately compared. Eddy and colleagues raise the important point that, as currently written, the diagnostic criteria for ARFID lack clarity on whether individuals with psychosocial impairment secondary to ARFID symptoms can meet full diagnostic criteria even in the absence of weight loss, nutritional deficiency, and/or dependence on tube feeding or oral nutritional supplements. To that end, Zickgraf, Murray, Kratz, and Franklin (2019) provide data suggesting that, among those who present with selective/ neophobic ARFID symptoms and psychosocial impairment, individuals who do not meet the additional weight/nutritional criteria do not differ meaningfully from those who do. These findings provide preliminary support for a proposal currently before the American Psychiatric Association to allow psychosocial impairment alone to be sufficient to meet criterion A for ARFID.
The final two papers in this group describe the first structured clinical interviews for ARFID that can be used to confer diagnoses and obtain dimensional scores of psychopathology severity: the Pica, ARFID, and rumination disorder interview (PARDI) ; and the ARFID module of the eating disorder examination (Schmidt, Kirsten, Hiemisch, Kiess, & Hilbert, 2019) . Both are welcome additions to the literature as they will enable clinicians and researchers to more rigorously establish the prevalence of ARFID in epidemiological studies, separate individuals with ARFID from healthy controls in biological studies, and evaluate outcomes from novel treatments. Indeed, application of the concepts and tools from Eddy et al. 
| CLINICAL PHENOMENOLOGY OF ARFID
In the eating-disorder field's excitement over a diagnosis that is new to us, we must remember that a dedicated group of clinicians and researchers has been treating and studying a subset of children with ARFID-referred to as pediatric feeding disorder-for several decades.
In their commentary, Sharp and Stubbs (2019) , experts from the feeding disorders community, remind us that studying ARFID from the perspective of eating disorders alone may lead us to miss important medical comorbidities or feeding skill deficits that are well-known to those who treat feeding disorders. They argue that subtyping ARFIDperhaps by age of onset and whether eating difficulties involve volume and/or variety-may help to guide research and intervention going forward. Interestingly, Zickgraf, Lane-Loney, Essayli, and Ornstein (2019) provide data on potential ARFID subtypes, finding five in their pediatric ARFID sample including selective eating, appetite disturbance, both selective eating and appetite disturbance, fear, and other disordered eating (e.g., features of both ARFID and AN), with differences across groups in terms of age. Empirical studies like this one are critical so that we may identify more homogeneous subgroups with the heterogeneous ARFID diagnosis that may have different underlying neurobiology and require different treatment approaches.
In their paper, Krom et al. (2019) examine parent/caregiver-reported quality of life in young children (ages 0-10 years) with ARFID in comparison to both healthy and chronically ill controls. Across childhood, quality of life was impaired-but variably by age-in ARFID compared to healthy controls, particularly on psychosocial and school functioning; impairments relative to chronically ill controls emerged in early childhood but less so in youth 6-10 years. These data underscore the broad quality of life impairments associated with the spectrum of ARFID and help to contextualize the often severe psychosocial impairments evident in adolescent and adult patients with ARFID amassed over what has often become a long-term illness at treatment presentation.
| SIMILARITIES AND DIFFERENCES BETWEEN ARFID AND AN
As restrictive eating disorders, both ARFID and AN can present with similar signs and symptoms including food restriction and avoidance and-in all cases of AN and a subset of cases with ARFID-low weight.
In prototypical cases, differential diagnosis is straightforward, but in other cases (e.g., a low-weight adolescent girl who denies shape and weight concerns yet eats very little) the distinction is less clear.
Izquierdo et al. (2019) compared children and adolescents with fat-
phobic AN, non-fat-phobic AN, and ARFID to healthy controls on a behavioral task, which revealed stronger implicit associations between pro-dieting and true statements in both AN groups compared to the ARFID and control groups, who themselves showed stronger associations between pro-dieting and false statements. It is possible that, in the future, performance-based tasks could represent a helpful tool for differential diagnosis in ambiguous cases of restrictive eating disorders. The other two papers in this category looked at short-and longterm outcomes in ARFID versus AN. Makhzoumi et al. (2019) report that post-treatment outcomes for underweight youth with ARFID and AN were similar for both groups in terms of BMI, though individuals with ARFID reported significantly more gastroenterological problems and were slower to gain weight. With regard to long-term outcomes, Lange and Wallin (2019) report similar outcomes at 15.9-year followup among those treated for childhood-onset AN versus low-weight ARFID. Roughly one quarter of those with ARFID met criteria for ARFID at long-term follow-up compared to one-fifth of those with childhood-onset AN who met criteria for AN or a related eating disorder at follow-up, suggesting the likelihood that, in both patient groups, a subset remains chronically ill. tolerate and accept distressing visceral (e.g., fullness) and emotional (e.g., disgust) sensations in order to increase food intake. If this mechanism is common across restrictive eating disorders, it could be an important transdiagnostic treatment target.
| NOVEL TREATMENTS FOR ARFID

| NEW IDEAS FOR IMPROVING TREATMENT OUTCOMES IN AN
The final group of papers focused on AN specifically. Kaplan and Strober (2019) highlight the sobering reality that a significant minority of individuals with AN will go on to develop a severe and enduring illness, lament our inability to predict this eventuality in young people in the earliest phases of illness, and underscore the current dearth of early interventions that may reliably prevent this undesirable outcome.
On a more hopeful note, Lock and Le Grange (2019) 
| CONCLUSIONS
It was a pleasure to curate this special issue on child and adolescent eating disorders for IJED readers. Given the newness of ARFID to the eating disorders field specifically, this special issue necessarily contained a higher proportion of commentaries and case reports than a regular issue of the journal. However, we hope that the exciting concepts and ideas described herein will galvanize your clinical and research practice. We are confident that future research on these topics will comprise high-quality empirical studies based on the seminal ideas described in the papers that follow.
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